People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other ...

Frozen pizzas were always seen as quick foods rather than wholesale, well-rounded meals... until now. Nestlé has helped ...

This experimental pill helped people lose about 16% of their body weight after about a year of treatment ...

For in-store pharmacy chains, the rise of weight-loss drugs represents a business opportunity to reshape shopping habits.

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

A Webb City woman experienced severe illness after accidentally overdosing on GLP-1 medication, which she hopes will serve as a warning to others about the potential negative effects of the drug.

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also ...